• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER KNEE CREATIONS, INC. ACCUFILL 5CC; CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER KNEE CREATIONS, INC. ACCUFILL 5CC; CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER Back to Search Results
Model Number N/A
Device Problem Insufficient Information (3190)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/20/2012
Event Type  Injury  
Manufacturer Narrative
During a clinical study review it was discovered that a patient who had received the subchondroplasty procedure later on received a total knee arthroplasty.Investigation is still on going so a supplemental to this mdr will be forthcoming once the investigation is completed.The issue was reported as such: subject was seen post-operatively (b)(6) 2012 with complaint of pain and swelling, along with signs of infection.The knee was aspirated and fluid was sent for cell count, culture and sensitivity, and gram stain.Due to subject¿s discomfort and malaise, arthroscopic lavage was performed with evacuation of hematoma on the same day and antibiotics were delivered.After this she was hospitalized due to septic knee and a picc line was started with vancomycin for 6 weeks per infectious disease consult.Subject had serial aspirations for cell count reports due to recurrence of effusion and high wbc count ranging from 34,000 to 40,000, however all cultures were negative.Subject was seen post-operatively (b)(6) 2012 with progression of knee infection.Additionally, subject displayed a full body rash and swelling in her hands and feet, which was attributed to an allergic reaction to her vancomycin therefore she was switched to daptomycin and given an epi pen.Following a second opinion to verify subject¿s septic condition, subject underwent diagnostic arthroscopy with lavage and light synovectomy with removal of all exudative material on (b)(6) 2012.Subject underwent an additional arthroscopic lavage (b)(6) 2012, as well as an additional diagnostic arthroscopy with lavage, decortication and drilling of lateral aspect of patella, extra articular and aspirate from knee sent for cell count and culture and sensitivity and bone biopsy sent for culture and sensitivity.During subject¿s post-operative visit on (b)(6) 2013, she reported intermittent sharp pain deep within her kneecap.She reported improvement, but no resolution of her swelling.Dr.(b)(6) suggested that if subject needed surgical intervention in the future she would be pre-approved for patellar osteochondral allograft transplantation, however he would like to postpone future surgery as long as possible.Dr.(b)(6) ultimately reported subject¿s septic knee of moderate severity, definitely related to scp procedure and possibly reported to the study device.He recorded the stop date of subject¿s septic knee to be (b)(6) 2013, the subject¿s post-operative clinic visit.
 
Event Description
Clinical subject.
 
Manufacturer Narrative
A review of documents has concluded that the swelling of the knee and subsequent "general feeling of malaise" could have been a result of the subchondroplasty procedure.However, this can't be confirmed as the culture and sensitivity reports were non-conclusive and no product was returned for analysis.
 
Event Description
Clinical subject was seen post-operatively (b)(6) 2012 with complaint of pain and swelling, along with signs of infection.The knee was aspirated and fluid was sent for cell count, culture and sensitivity, and gram stain.Due to subject¿s discomfort and malaise, arthroscopic lavage was performed with evacuation of hematoma on the same day and antibiotics were delivered.After this, she was hospitalized due to septic knee and a picc line was started with vancomycin for 6 weeks per infectious disease consult.Subject had serial aspirations for cell count reports due to recurrence of effusion and high wbc count ranging from 34,000 to 40,000, however all cultures were negative.Subject was seen post-operatively (b)(6) 2012 with progression of knee infection.Additionally, subject displayed a full body rash and swelling in her hands and feet, which was attributed to an allergic reaction to her vancomycin therefore she was switched to daptomycin and given an epi pen.Following a second opinion to verify subject¿s septic condition, subject underwent diagnostic arthroscopy with lavage and light synovectomy with removal of all exudative material on (b)(6) 2012.Subject underwent an additional arthroscopic lavage (b)(6) 2012, as well as an additional diagnostic arthroscopy with lavage, decortication and drilling of lateral aspect of patella, extra articular and aspirate from knee sent for cell count and culture and sensitivity and bone biopsy sent for culture and sensitivity.During subject¿s post-operative visit on (b)(6) 2013, she reported intermittent sharp pain deep within her kneecap.She reported improvement, but no resolution of her swelling.Dr.(b)(6) suggested that if subject needed surgical intervention in the future, she would be pre-approved for patellar osteochondral allograft transplantation, however he would like to postpone future surgery as long as possible.Dr.(b)(6) ultimately reported subject¿s septic knee of moderate severity, definitely related to scp procedure and possibly reported to the study device.He recorded the stop date of subject¿s septic knee to be (b)(6) 2013, the subject¿s post-operative clinic visit.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUFILL 5CC
Type of Device
CALCIUM PHOSPHATE COMPOUND BONE VOID FILLER
Manufacturer (Section D)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
Manufacturer (Section G)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
Manufacturer Contact
shari bailey
841 springdale drive
exton, PA 19341
4848794543
MDR Report Key6131867
MDR Text Key61020061
Report Number3008812173-2016-00030
Device Sequence Number1
Product Code MQV
Combination Product (y/n)N
PMA/PMN Number
PN/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number201.050
Device Lot NumberN/A
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/25/2016
Initial Date FDA Received11/29/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/10/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age28 YR
Patient Weight78
-
-